Hims & Hers
Hims & Hers, Novo Nordisk Reunite in GLP-1 Deal Weeks After Lawsuit
Hims & Hers and Novo Nordisk are partners again, just weeks after Novo sued the telehealth giant for selling compounded GLP-1s.
Former Hims Execs Are Betting on the Fiber Boom With Sweetener Pouches
Hims co-founder Hilary Coles and former marketing head Emily Boschwitz have launched Poca, a fiber-filled, zero-calorie syrup sweetener.
Hims & Hers Goes Global While GLP-1 Drama Plays Out at Home
Hims & Hers is planting its flag in new overseas markets; on U.S. soil, it's navigating a GLP-1s fight against Big Pharma's branded blockbusters.
Amazon Enters Lab-Testing Race Through Lifeforce Partnership
Amazon just became the next major player to enter the biomarker blood testing wars with the launch of Health Insights.
Super Bowl Advertisers Are Playing Offense on Wellness
This year's Super Bowl LX ad slate shows just how much has changed in the conversation around health and wellness.
Hims & Hers Wants To ‘Ruffle Some Feathers’ With Provocative Super Bowl Ad
Hims & Hers returns to the Super Bowl with a pointed ad that takes aim at the health-wealth gap in the United States.
ATN Week in Review: The Blood-Testing Era Is Here
ATN breaks down Function Health's huge funding round and Hims & Hers' entry into blood testing, as well as the rise of in-person wellness events.
Hims & Hers Enters Blood Testing Amid Preventive Health Surge
Hims & Hers has launched Labs, a subscription diagnostic service offering blood testing as consumers face rising healthcare costs.
Hers Launches Menopause Specialty, Paving the Way to $1B in Revenue in 2026
Telehealth giant Hims & Hers has expanded into women's midlife care with personalized treatment plans, including patches, creams and pills.
Hims & Hers Shows Personalized GLP-1 Plans Are Driving Real Results
New internal data suggests that Hims & Hers tailored weight loss model is improving outcomes and helping patients stick with their treatment.
